| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.2M | — | -95.0% |
| R&D Expense | $44.1M | — | +36.9% |
| SG&A Expense | $10.2M | — | +16.9% |
| Operating Income | -$50.0M | — | -213.6% |
| Pre-tax Income | -$44.5M | — | -193.2% |
| Income Tax | $52K | — | -93.7% |
| Net Income | -$44.5M | — | -194.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $159.9M | +23.1% | +103.6% |
| Current Assets | $677.5M | +72.3% | +103.9% |
| Total Assets | $736.4M | +64.1% | +87.3% |
| Current Liabilities | $71.0M | +10.6% | +20.0% |
| Total Liabilities | $214.5M | -0.5% | +81.7% |
| Stockholders' Equity | $521.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$37.4M | — | +17.9% |
| Capital Expenditures | $1.9M | — | +17.7% |
| Investing Cash Flow | -$261.0M | — | -160.4% |
| Financing Cash Flow | $328.3M | — | — |
| Free Cash Flow | -$39.2M | — | +16.7% |
| +89.7% |